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Abstract
Background: The prognostic role of what a surgeon observes in the abdomen of patients with complicated intra-
abdominal infection (cIAI) is largely unknown. The aim of this prospective study was to systemically analyze
components of the intra-abdominal view (IAV) and their association to severe complicated intra-abdominal sepsis
(SCIAS) or mortality.
Methods: The study cohort consisted of adult patients with cIAI. The operating surgeon filled a paper form
describing the intra-abdominal view. Demographics, operative details, and preoperative physiological status were
collected. Descriptive, univariate, and multivariate statistical analyses were performed, and a new score was
developed based on regression coefficients. The primary outcome was a composite outcome of SCIAS or 30-day
mortality, in which SCIAS was defined as organ dysfunctions requiring intensive care unit admission.
Results: A total of 283 patients were analyzed. The primary outcome was encountered in 71 (25%) patients. In the
IAV, independent risk factors for the primary outcome were fecal or bile as exudate (odds ratio (OR) 1.98, 95%
confidence interval 1.05–3.73), diffuse peritonitis (OR 2.15, 1.02–4.55), diffuse substantial redness of the peritoneum
(OR 5.73, 2.12–15.44), and a non-appendiceal source of cIAI (OR 11.20, 4.11–30.54). Based on these factors, an IAV
score was developed and its performance analyzed. The area under the receiver operating characteristic for the IAV
score was 0.81. The IAV score also correlated significantly with several outcomes and organ dysfunctions.
Conclusions: The extent of peritonitis, diffuse substantial redness of the peritoneum, type of exudate, and source
of infection associate independently with SCIAS or mortality. A high IAV score associates with mortality and organ
dysfunctions, yet it needs further external validation. Combining components of IAV into comprehensive scoring
systems for cIAI patients may provide additional value compared to the current scoring systems.
Trial registration: The study protocol was retrospectively registered on April 4, 2016, right after the first enrolled
patient at Clinicaltrials.gov database (NCT02726932).
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Background
Perforation in the gastrointestinal tract results in com-
plicated intra-abdominal infection (cIAI) that may
present either as localized peritonitis with or without ab-
scess formation or as diffuse peritonitis [1]. The
intra-abdominal view (IAV) in cIAI is traditionally classi-
fied into generalized or local and clear, purulent, or fecal
according to the appearance of the exudate in the
abdomen [2]. Other classifications separate community-
or hospital-acquired cIAIs and postoperative or
non-postoperative IAIs [3].
In a cIAI, various other findings are often seen in the
abdomen, for example, bowel dilatation, bile as exudate,
various degrees of fibrin coverage, and redness in the
parietal and/or visceral peritoneum.
Even though all surgeons know that a large variety in
the IAV exists in patients with cIAI, IAV has not re-
ceived much attention in previous literature or clinical
work. As an example, a patient with acute perforated di-
verticulitis and a small amount of pus in the pelvis and
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among small bowel loops, in an otherwise perfectly nor-
mally looking abdomen, would be classified as Hinchey
III [4]. The same grade of classification would be used in
an abdomen full of pus, with dilated bowel, extensive
fibrin coverage, and substantially red peritoneal surfaces
all over the abdomen. It seems intuitive that recovery
paths of these patients would be different and, therefore,
all Hinchey III patients cannot be considered equal only
based on the existence of purulent peritonitis [5, 6].
There is a wide range of disease severity in patients
with cIAI. A term severe complicated intra-abdominal
sepsis (SCIAS) to describe sepsis-related organ dysfunc-
tions combined with cIAI specifically due to a disruption
in the gastrointestinal tract was introduced in an article
by Kirkpatrick et al. [7]. A variety of risk factors for
SCIAS or mortality have been identified, preoperative
sepsis with associated organ dysfunctions and septic
shock being the most important ones [3, 8–10]. Other
crucial factors include the physiological reserve of the
patient, comorbidities, immunosuppressive medications,
and the anatomical derangement caused by the acute
disease. There are multiple scoring systems, general and
cIAI-specific combining these factors to predict severe
outcomes but no one system works satisfyingly [11].
These systems include limited data of the IAV.
The aim of this prospective study was to systematically
analyze components of IAV and their association to
SCIAS or 30-day mortality.
Methods
Patients and setting
This study was conducted as a prospective cohort study
in a single academic center that serves both as a second-
ary and a tertiary referral center. Institutional ethics
committee and review board approved the study design.
A written informed consent was obtained from all the
patients included in the study. The study period was
2 years, starting on 31 March 2016 and ending on 31
March 2018.
Eligible patients were adult (over 18 years old) patients
undergoing surgical intervention because of a cIAI.
Patients with pancreatitis, acute mesenteric ischemia, or
trauma were excluded. During the study period, elec-
tronic operating room logs were manually browsed for
all abdominal emergency operations to verify that all
patients with a cIAI were identified.
Intra-abdominal view
Data regarding intra-abdominal findings was collected
on a paper sheet form filled by the operating surgeon
after the operation (Additional file 1). In the form, the
abdomen was divided into six areas: right and left upper
supramesocolic area, right and left lower and paracolic
area, mid-abdomen small bowel area, and pelvic area
(below the promontorium). Small and/or large bowel
dilatation was recorded as well as the type of exudate
(clear, purulent, fecal, bile) by area. If any area contained
fecal or bile exudate, the peritonitis was classified as fecal
or bile peritonitis, respectively. If both were present, the
peritonitis was classified according to the predominant
exudate. In addition, the amount of fibrin by area (none,
mild, or substantial) and redness of the peritoneum by
area (none, mild, or substantial) were recorded. Further,
the localization of infection in the peritoneum by area
(parietal and/or visceral, excluding the pelvic area) was
recorded. The difference between mild and substantial
finding was a subjective estimation based on clinical judg-
ment and experience.
Definitions
Comorbidities were classified according to the Charlson
Comorbidity Index [12]. The classification of sepsis was
recorded as in the Sepsis-III guidelines, i.e., sepsis is an
acute change of total Sequential Organ Failure Assess-
ment (SOFA) score two or more and septic shock is
sepsis with persisting hypotension requiring vasopressors
to maintain mean arterial pressure ≥ 65mmHg and a per-
sistent serum lactate level > 2mmol/l despite adequate
volume resuscitation [10]. Other reported scores were the
Mannheim Peritonitis Index, World Society of Emergency
Surgery (WSES) Sepsis Severity Score for patients with
cIAIs, Acute Physiology And Chronic Health Evalu-
ation II (APACHE-II), Clavien-Dindo complication
classification, and the SOFA scores in patients admitted to
the ICU [2, 13–16]. For the Clavien-Dindo classification,
the most serious in-hospital complication was used. Pre-
operative organ dysfunctions (grade IV) or antibiotic treat-
ment for cIAI were not documented as complications.
Only new onset organ dysfunctions or complications that
significantly contributed to the worsening of preoperative
organ dysfunctions were classified as grade IV [17].
Immunosuppression was defined according to the WSES
Sepsis Severity Score, i.e., chronic use of glucocorticoids,
immunosuppressive medication, chemotherapy within 30
days, or lymphatic disease. The primary outcome was a
composite outcome of SCIAS or 30-day mortality. SCIAS
translated to ICU admission due to organ dysfunctions.
Similar definition has also been used in a recent study [11].
Statistical analyses
Descriptive statistics are demonstrated in number,
percentage, mean, median, and interquartile range
(IQR), where appropriate. Univariate analyses were made
using binary logistic regression for categorical variables,
Mantel-Haenszel linear-by-linear association chi-squared
test for ordinal variables, and Mann-Whitney U test or
Kruskal-Wallis test for continuous variables without
normal distribution, where appropriate. Nonparametric
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correlations between continuous variables were tested
with Spearman’s rho test. Multivariate analysis was con-
ducted using binary logistic regression. Multivariate
goodness-of-fit was tested using Hosmer-Lemeshow test,
and model performance was tested using Nagelkerke R2.
Variables for multivariate analysis were chosen from the re-
sults of the univariate analysis. After logical reclassification
in some variables, the most significant variable from each
IAV component (perforated organ, extent of peritonitis,
bowel dilatation, type of exudate, fibrin coverage, and red-
ness in peritoneum) was chosen. Different logistic regres-
sion models were tested with different combinations of
variables, and the model with the highest Nagelkerke R2
value was chosen. The scoring system was built according
to the regression coefficients in the logistic regression equa-
tion. A receiver operating characteristic (ROC) curve was
plotted, and area under ROC curve (AUROC) calculated.
Two-tailed P value below 0.05 was considered significant,
and odds ratio (OR) values are presented with 95% confi-
dence intervals (CI). Analyses mentioned above were per-
formed using a SPSS© Statistics version 22 for Mac (IBM©,
Armonk, NY, USA). Internal validation on logistic model
was done with bootstrapping and by calculating
optimism-adjusted AUC [18]. This analysis was done using
R (R Foundation for Statistical Computing, Vienna, Austria.
URL https://www.R-project.org/.) with pROC package [19]
and R function for optimism-adjusted AUC [20].
Power calculation
Power calculations for this study were based on the pri-
mary outcome measure, i.e., SCIAS or 30-day mortality.
In order to perform a statistically appropriate multivari-
ate analysis with seven variables, we calculated the need
for a minimum of 49 patients with the primary outcome
event. Based on previous reports, 10–25% of patients
with cIAI will meet the primary outcome [8, 13]. For
power calculation purposes, we estimated that 17% of
cIAI patients would meet the primary outcome event
resulting in a need to recruit at least 288 patients.
Results
During the 2-year study period, there were 657 operated
patients with cIAIs filling the inclusion; please see the
modified flow diagram (Fig. 1). The most common rea-
sons for not recruiting patients were failure to attempt
recruiting and not suspecting cIAI preoperatively.
A total of 283 patients with properly filled IAV form
were included and analyzed. Patient characteristics, to-
gether with the intra- and postoperative data, are pre-
sented in Table 1, describing the study cohort. Briefly,
Fig. 1 Patient flow chart
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132 (47%) were male with a median age of 64 years. Sep-
sis was present in 60 (21%) and septic shock in 19 (7%)
patients preoperatively. The most common sources of
cIAI were the appendix (n = 109, 39%) and colorectal (n
= 101, 36%). The median length of hospital stay was
6 days, and 57 (20%) patients were admitted to the ICU
with a median peak SOFA score of 8. All patients admit-
ted to the ICU had a SOFA score of at least 1.
Twenty-nine (10%) patients died within 30 days, and
SCIAS or mortality was encountered in 71 (25%)
patients.
Several different components of the IAV were associ-
ated with the primary outcome (Table 2). Some compo-
nents of the IAV were reclassified according to the
results to build the multivariate analysis (marked with
“*” in Table 2). Non-appendiceal source of cIAI, diffuse
peritonitis (four or more out of six areas), dilatation of
the colon only, fecal or bile as exudate, substantial fibrin
deposits found in five or more areas, and substantial
redness found in four or more areas were chosen for the
multivariate analysis. Correlations between continuous
variables were tested, and all results were significant (P
< 0.001). Correlation coefficients for the amount of sub-
stantial redness by area were 0.433 for the amount of
substantial fibrin by area and 0.385 for the extent of
peritonitis by area. For the amount of substantial fibrin
by area and extent of peritonitis by area, the correlation
coefficient was 0.293.
In the multivariate binary logistic regression analysis,
four components of the IAV were found independently
significantly associated with the primary outcome
(Table 3). In an ascending OR order, these factors were
fecal or bile as exudate, diffuse peritonitis, substantial red-
ness in four or more areas, and a non-appendiceal source.
AUROC for this logistic model was 0.812 (95% CI 0.761–
0.865). Internal validity of the logistic model was tested
with bootstrapping. Distribution of the AUROC value in
the bootstrap sample is shown in Additional file 2.
Optimism-adjusted AUROC for the logistic model was
0.802. Hosmer-Lemeshow goodness-of-fit test significance
Table 1 Patient characteristics
Preoperative n (%) (total n = 283)
Sex, male 132 (47)
Age, years 64 (49–74)a
BMI 21 (19–24)a
Charlson Comorbidity Index 1 (0–5)a
Immunosuppression 54 (19)
Malignant diseases
Local solid malignant tumor 35 (12)
Solid metastatic tumor or lymphoma 45 (16)
Sepsis classification
No sepsis 204 (72)
Sepsis 60 (21)
Septic shock 19 (7)
Hospital-acquired cIAI 62 (22)
Intraoperative n (%)
Delay from symptoms to operation < 24 h 79 (28)
Perforated organ
Gastroduodenal 32 (11)







Converted from laparoscopy to laparotomy 21 (7)
Open abdomen 5 (2)
Postoperative peritonitis 38 (13)
Mannheim Peritonitis Index 26 (22–32)a
WSES Sepsis Severity Score 6 (3–9)a
APACHE-II 9 (6–15)a
Postoperative n (%)
CRP, highest value, mg/l 304 (244–364)a
Reoperations 36 (13)










Length of hospital stay, days 6 (3–11)a
Table 1 Patient characteristics (Continued)
ICU admission 57 (20)
Renal replacement therapy 2 (1)
Peak SOFA score at ICU 8 (6–10)a
Prolonged (> 12 h) recovery room stay 25 (9)
Mortality, 30 days 29 (10)
SCIAS or 30-day mortality 71 (25)
Mortality, 90 days 37 (13)
Abbreviations: BMI body mass index, cIAI complicated intra-abdominal
infection, WSES World Society of Emergency Surgery, APACHE Acute
Physiology and Chronic Health Evaluation, CRP C-reactive protein, ICU
intensive care unit, SCIAS severe complicated intra-abdominal sepsis
aContinuous variables are presented as median (interquartile range)
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Table 2 Univariate binary logistic regression of components of the intra-abdominal view for severe complicated intra-abdominal
sepsis (SCIAS) or 30-day mortality
Risk factor n (%) SCIAS or 30-day mortality, n (%) OR (95% CI) P value B
Perforated organ
Appendix 109 (39) 5 (5) Reference < 0.001
Gallbladder 11 (4) 4 (36) 11.89 (2.60–54.42) 0.001 2.475
Colorectal 101 (36) 37 (37) 12.03 (4.49–32.18) < 0.001 2.487
Gastroduodenal 32 (11) 12 (38) 12.48 (3.96–39.33) < 0.001 2.524
Small bowel 30 (11) 13 (43) 15.91 (5.03–50.33) < 0.001 2.767
Non-appendiceal source* 174 (62) 66 (38) 12.71 (4.93–32.81) < 0.001 2.542
Extent of peritonitis by number of affected areas
1 30 (11) 4 (13) Reference 0.001
2 47 (17) 7 (15) 1.14 (0.30–4.28) 0.849 0.129
3 29 (10) 1 (3) 0.23 (0.02–2.21) 0.204 − 1.460
4 32 (11) 8 (25) 2.17 (.58–8.13) 0.252 0.773
5 32 (11) 7 (22) 1.82 (0.47–6.99) 0.383 0.599
6 113 (40) 44 (39) 4.15 (1.35–12.69) 0.013 1.422
Diffuse peritonitis (≥ 4 areas)* 177 (63) 59 (33) 3.92 (1.99–7.71) < 0.001 1.365
Bowel dilatation
No bowel dilatation 164 (58) 35 (21) Reference 0.097
Small bowel only 77 (27) 19 (25) 1.21 (0.64–2.29) 0.563 0.188
Colon only* 19 (7) 8 (42) 2.68 (1.00–7.17) 0.050 0.986
Small bowel and colon 23 (8) 9 (39) 2.37 (0.95–5.93) 0.065 0.863
Type of exudate
Clear 16 (6) 3 (19) Reference 0.001
Purulent 160 (57) 27 (17) 0.88 (0.24–3.30) 0.849 − 0.128
Fecal 85 (30) 30 (35) 2.36 (0.62–8.95) 0.206 0.860
Bile 22 (8) 11 (52) 4.33 (0.96–19.58) 0.057 1.466
Fecal or bile* 107 (38) 41 (38) 3.02 (1.74–5.26) < 0.001 1.106
Extent of fibrin by number of affected areas
0 37 (13) 15 (41) Reference < 0.001
1 77 (27) 12 (16) 0.27 (0.11–0.67) 0.004 − 1.306
2 46 (16) 7 (15) 0.26 (0.09–0.74) 0.120 − 1.335
3 28 (10) 3 (11) 0.18 (0.05–0.69) 0.130 − 1.737
4 31 (11) 6 (19) 0.35 (0.12–1.06) 0.640 − 1.044
5 24 (9) 10 (42) 1.05 (0.37–2.98) 0.930 0.047
6 39 (14) 18 (46) 1.26 (0.51–3.12) 0.622 0.229
Amount of substantial fibrin by number of affected areas
0 140 (49) 33 (24) Reference 0.016
1 72 (25) 12 (17) 0.65 (0.31–1.35) 0.246 − 0.433
2 25 (9) 6 (24) 1.02 (0.38–2.78) 0.963 0.024
3 19 (7) 7 (37) 1.89 (0.69–5.20) 0.216 0.637
4 10 (4) 2 (20) 0.81 (0.16–4.01) 0.797 − 0.210
5 6 (2) 4 (67) 6.49 (1.14–37.01) 0.035 1.869
6 11 (4) 7 (64) 5.67 (1.56–20.59) 0.008 1.736
Substantial fibrin ≥ 5 or more areas* 17 (6) 11 (65) 6.29 (2.2–17.73) < 0.001 1.840
Tolonen et al. World Journal of Emergency Surgery           (2019) 14:15 Page 5 of 10
was 0.36 showing the model had adequate fit. Model per-
formance was tested using Nagelkerke R2 with a result of
0.36.
The IAV score is also presented in Table 3. Regression co-
efficients were multiplied by 1.3, and the nearest integer
was the score for each variable. AUROC for IAV score pre-
dicting SCIAS or 30-day mortality was 0.81, and it
remained unchanged from the original logistic model. As
shown in Fig. 2, the IAV score performed nearly as good as
other scores in predicting SCIAS or mortality. With the
help of the ROC curve (Fig. 2), two cutoff points were
chosen to divide patients to low (0–2 points), medium (3–5
points), and high score (6–7 points) groups. These groups
were compared for various different outcomes (Table 4).
Because of the dynamic nature of organ dysfunctions,
an additional analysis was made to evaluate whether
the IAV score could predict the course of organ dys-
function (Fig. 3). Patients with preoperative organ dys-
functions had a higher median IAV score (4, IQR 4–5)
compared to patients without organ dysfunctions (3,
IQR 1–4), P < 0.001. Of the 204 patients without pre-
operative organ dysfunctions, 13 (6%) were admitted to
the ICU or died, and these patients had a significantly
higher IAV score (4, IQR 3–5) compared to the patients who
recovered without ICU treatment (3, IQR 1–4), P= 0.008.
On the other hand, patients whose preoperative organ dys-
functions resolved quickly without ICU treatment had a
lower IAV score (3, IQR 1–4) compared to the ones who
were admitted to the ICU or died (5, IQR 4–6), P < 0.001.
Subgroup analysis
Due to the much better prognosis in acute appendicitis as
the source of cIAI, we performed a subgroup analysis with
a non-appendiceal source of cIAI. There were 174 pa-
tients, of which 27 (16%) died within 30 days, 53 (30%)
were admitted to the ICU, and 66 (38%) had a SCIAS. A
multivariate analysis was performed with the Table 3 vari-
ables, without source of infection, using the enter method.
The results were substantial redness in ≥ 4 areas (OR 5.09,
95% CI 1.71–15.13, P 0.003, B 1.628), fecal or bile as exudate
(OR 2.06, 95% CI 1.06–4.03, P 0.034, B 0.725), and diffuse
peritonitis (OR 2.14, 95% CI 0.97–4.72, P 0.059, B 0.761).
Hosmer-Lemeshow test showed a non-significant value of
0.91 and Nagelkerke R2 0.19.
Discussion
This pioneer prospective study of the IAV in patients
with cIAI recognized several independent factors associ-
ated with SCIAS or 30-day mortality. Based on these fac-
tors, an IAV score was developed and its performance
further analyzed.
We chose a composite outcome of either ICU admis-
sion due to acute organ dysfunctions (=SCIAS) or
30-day mortality as the primary outcome. All patients
Table 2 Univariate binary logistic regression of components of the intra-abdominal view for severe complicated intra-abdominal
sepsis (SCIAS) or 30-day mortality (Continued)
Risk factor n (%) SCIAS or 30-day mortality, n (%) OR (95% CI) P value B
Extent of redness by number of affected areas
0 17 (6) 8 (47) Reference < 0.001
1 41 (14) 6 (15) 0.19 (0.05–0.70) 0.012 − 1.646
2 55 (19) 7 (13) 0.16 (0.05–0.57) 0.004 − 1.808
3 32 (11) 3 (9) 0.12 (0.03–0.53) 0.006 − 2.151
4 32 (11) 7 (22) 0.32 (0.09–1.12) 0.074 − 1.155
5 27 (10) 7 (26) 0.39 (0.11–1.42) 0.155 − 0.932
6 78 (28) 33 (42) 0.83 (0.29–2.37) 0.720 − 1.192
Amount of substantial redness by number of affected areas
0 125 (44) 26 (21) Reference < 0.001
1 73 (26) 10 (14) 0.60 (0.27–1.34) 0.214 − 0.504
2 34 (12) 10 (29) 1.59 (0.68–3.73) 0.290 0.462
3 21 (7) 5 (24) 1.19 (0.40–3.55) 0.755 0.174
4 9 (3) 5 (56) 4.76 (1.19–18.99) 0.027 1.560
5 3 (1) 2 (67) 7.62 (0.66–87.29) 0.103 2.030
6 18 (6) 13 (72) 9.90 (3.24–30.29) < 0.001 2.293
Substantial redness ≥ 4 or more areas* 30 (11) 20 (67) 7.92 (3.49–17.97) < 0.001 2.070
Localization of cIAI non-parietal (only visceral) 49 (17) 11 (22) 0.84 (0.40–1.75) 0.639 − 1.094
Method: enter, all variables categorical. Italics indicate statistical significance
Abbreviations: OR odds ratio, B regression coefficient, cIAI complicated intra-abdominal infection
*Included in multivariate analysis
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admitted to the ICU had acute organ dysfunctions. With
this outcome, all patients with a severe outcome were
recognized, since some patients may die without being
admitted to the ICU. This may be due to ICU admission
refusals, or a more surprising death without diagnosed
previous organ dysfunctions.
The results from the multivariate analysis are some-
what expected. A completely new finding was that
having substantial redness in four or more out of six
areas in the abdomen was independently associated with
the primary outcome. Intuitively, it seems logical. The in-
flammatory response of the peritoneum is characterized
by enhanced vascular perfusion, accumulation of macro-
phages with subsequent attraction of more immune cells,
and release of pro- and anti-inflammatory mediators [21–
23]. The stronger the inflammation process, the more vis-
ible the redness of the peritoneum. Patients with appendi-
citis have substantially better prognosis compared to other
cIAIs [3, 13]. Even when adjusting for other IAV factors,
patients having other sources than appendicitis was the
risk factor with the highest OR. In future cIAI studies, it
should be considered if appendicitis should be studied as
a separate entirety with different outcome measures due
to a much less severe course of the disease. Having a dif-
fuse, rather than localized cIAI, the risk for SCIAS or
30-day mortality increased threefold. This risk seems obvi-
ous and has also been identified by the previously existing
scoring systems [2, 13]. When the type of exudate was
Table 3 Multivariate binary logistic regression of the intra-abdominal view for severe complicated intra-abdominal sepsis (SCIAS) or
30-day mortality
Risk factor SCIAS or 30-day mortality OR (95% CI) P value B IAV score
Exudate fecal or bile 1.98 (1.05–3.73) 0.034 0.685 1
Diffuse peritonitis (≥ 4 areas) 2.15 (1.02–4.55) 0.045 0.767 1
Substantial redness (≥ 4 areas) 5.73 (2.12–15.44) 0.001 1.745 2
Non-appendiceal source 11.20 (4.11–30.54) < 0.001 2.416 3
Method: forward LR, all variables categorical
Abbreviations: OR odds ratio, CI confidence interval, B regression coefficient, IAV intra-abdominal view (score = 1.3 × B to nearest integer)
Area Under ROC (95 % CI)
IAV Score 0.81 (0.76-0.87)
APACHE-II 0.85 (0.80-0.90)
Fig. 2 Receiver operating characteristic (ROC) curve for the intra-abdominal view (IAV) score and comparisons to other scores. Abbreviations:
WSES World Society of Emergency Surgery, APACHE Acute Physiology And Chronic Health Evaluation, MPI Mannheim Peritonitis index, CI
confidence interval
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fecal or bile, compared to clear or purulent, there was a
more than twofold increase for the primary outcome. This
factor is taken into account in the Mannheim Peritonitis
Index [2] but not in other cIAI-specific or sepsis scoring
systems [11, 13].
Fibrin coverage was not independently associated with
the primary outcome. Fibrin correlated with redness but
the redness was more significant in multivariate analysis
and therefore fibrin did not stand out as an independent
risk factor. Venous blood flow from the visceral periton-
eum goes first through the portal vein into the liver,
whereas parietal venous flow goes directly to systemic cir-
culation. Also, the visceral and parietal peritoneum have
distinct innervations and the surface area of the visceral
peritoneum is much larger than that of the parietal peri-
toneum [24]. However, localization of the cIAI only in the
visceral peritoneum did not correlate with outcome.
The values of Nagelkerke R2 0.36 and AUROC 0.81 for
the IAV score clearly show that IAV only accounts for a
limited, although substantial, part of prognostic factors
for SCIAS or 30-day mortality. However, it is quite sur-
prising that the AUROC for the IAV score is of the same
magnitude as in the more comprehensive scoring sys-
tems, since organ dysfunctions and comorbidities are
not included in the model [11]. These results emphasize
the role of the surgeons’ perception of cIAI disease
Table 4 The intra-abdominal view (IAV) score evaluation; low, middle, and high scores with various outcomes
All patients Low score Medium score High score P value*
IAV score 4 (1–4)** 0–2 3–5 6–7
Number of patients, n (%) 283 (100) 102 (36) 158 (56) 23 (8)
Length of stay, days** 6 (3–10) 3 (2–5) 8 (6–13) 10 (6–18) < 0.001
Clavien-Dindo ≥ 3, n (%) 87 (31) 14 (14) 62 (39) 11 (48) < 0.001
ICU admission, n (%) 57 (20) 2 (2) 39 (25) 16 (70) < 0.001
Mortality, 30 days, n (%) 29 (10) 1 (1) 22 (14) 6 (26) < 0.001
SCIAS or 30-day mortality, n (%) 71 (25) 3 (3) 50 (32) 17 (74) < 0.001
Abbreviation: ICU intensive care unit
*P values are calculated using linear-by-linear association for dichotomous variables and Kruskal-Wallis test for continuous variable
**Continuous variables are presented as median (interquartile range)
Fig. 3 The intra-abdominal view (IAV) score correlations with pre- and postoperative organ dysfunctions. Legend: IAV scores are presented as
median (interquartile range), *Mann-Whitney U test
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severity when looking into the abdomen while operating.
A subgroup analysis of patients with a non-appendiceal
source of cIAI showed very similar results and was not
considered to provide any additional value.
The IAV score was tested by dividing patients into
three score groups (Table 4), and it was found to correl-
ate significantly with a variety of different outcomes. In
Fig. 3, it is shown that patients who improve quickly,
without ICU treatment, from preoperative organ dys-
functions have a lower IAV score. In addition, patients
without preoperative organ dysfunctions who eventually
develop SCIAS or die have a higher score than patients
who recover without organ dysfunctions. It is not sur-
prising that the worse the macroscopic view of the peri-
tonitis is, the worse the outcome. Nevertheless, this is
the first study that shows and quantifies it.
Interestingly, in the univariate analyses, when the ex-
tent of fibrin and the redness by area was zero, the risk
for the primary outcome was high, resulting in a
U-shaped curve within the variable. The reason for this
finding can only be speculated and it warrants further
research, but the phenomenon might be associated with
an impaired immune response to cIAI.
It is well known that organ dysfunctions are the most
important risk factors for poor outcome [8, 11, 13]. An-
other major factor not included in this study’s model is
the comorbidities. These factors were not included in
this study since the focus of this study was an in-depth
analysis of the IAV. In future studies, including compo-
nents of the IAV to a more comprehensive scoring sys-
tem could provide a better scoring system than the
current ones.
This study has some limitations. This was a pro-
spective single-center study with a limited number of
patients. Less than half of the recruitable patients
during the study period were included in the study.
The evaluation of the amount of fibrin deposits as
well as redness of the peritoneum was based on sub-
jective evaluation leading most likely into some inter-
observer variability. Also, the IAV score has not been
externally validated.
Conclusions
Classification of peritonitis should not be based only
on the type of the exudate or presence of diffuse
peritonitis. An IAV score, which includes fecal or bile
as exudate, diffuse peritonitis, substantial redness in
four or more of the six areas of the abdomen, and
non-appendiceal source of cIAI, may provide a simple
method to classify patients with cIAI. The IAV score
predicts various outcomes well and correlates with
preoperative organ dysfunctions and the development
of postoperative organ dysfunctions. The concept of
including more variables of the IAV to cIAI scoring
systems might provide additional value in assessing
individual patient disease severity and outcome. How-
ever, the IAV score needs external validation before
further implementations.
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